METTL5 and nasopharyngeal carcinoma: For example, nasopharyngeal carcinoma (NPC) exhibits elevated levels of METTL5/TRMT112 and its m6A modification at 18S rRNA position 1832 (m6A1832), which enhances neoplastic transformation both in vitro and in vivo.